INHIBITION OF NITRIC-OXIDE SYNTHASE DOES NOT PREVENT THE INDUCTION OFLONG-TERM POTENTIATION IN-VIVO

Citation
Dm. Bannerman et al., INHIBITION OF NITRIC-OXIDE SYNTHASE DOES NOT PREVENT THE INDUCTION OFLONG-TERM POTENTIATION IN-VIVO, The Journal of neuroscience, 14(12), 1994, pp. 7415-7425
Citations number
54
Categorie Soggetti
Neurosciences,Neurosciences
Journal title
ISSN journal
02706474
Volume
14
Issue
12
Year of publication
1994
Pages
7415 - 7425
Database
ISI
SICI code
0270-6474(1994)14:12<7415:IONSDN>2.0.ZU;2-Z
Abstract
Nitric oxide (NO), a putative intercellular messenger in the CNS, may be involved in certain forms of synaptic plasticity and learning. This article reports a series of experiments investigating whether an inhi bitor of NO synthase, N-omega-nitro-L-arginine methyl ester (L-NAME), affects long-term potentiation (LTP) in vivo, as the results of recent in vitro experiments would predict. L-NAME, given as an acute injecti on at a dose sufficient to inhibit hippocampal NO synthase (>90%), had no effect on perforant path-dentate gyrus LTP induced by a strongly s uprathreshold tetanus, but appeared to impair LTP induced by a weak ne ar-threshold tetanus that may be more physiologically relevant. Howeve r, subsequent studies revealed that chronic L-NAME treatment (>95% inh ibition of NO synthase) had no effect upon LTP induction, and that acu te (but not chronic) treatment resulted in a gradual but significant r eduction in nontetanized baseline field potentials. The baseline shift appeared to be of a magnitude sufficient to account for the apparent impairment of weak tetanus-induced LTP. This possibility was further e xamined in a two-hemisphere experiment in which the time course of cha nges in the field EPSP of the nontetanized pathway served as the withi n-subject control for the tetanized pathway. No impairment of LTP indu ction was observed; indeed, if anything, there was a trend for greater potentiation with L-NAME. Because NO has also been implicated in the control of vasodilation, the effect of L-NAME on cerebrovascular funct ion was also investigated. Peripheral blood pressure was significantly increased by L-NAME at the same dose that affected the field EPSP. Lo cal cerebral glucose utilization was unchanged, while local cerebral b lood flow decreased significantly in various brain regions, including the hippocampus, indicating an uncoupling of cerebral metabolism and b lood flow. Thus, while NO synthase inhibition does not appear to limit the induction of LTP in vivo, it does reduce the size of baseline fie ld EPSPs and affect local cerebrovascular function.